TY - JOUR
T1 - Transgenic Chlamydomonas Expressing Human Transient Receptor Potential Ankyrin 1 (TRPA1) Channels to Assess the Effect of Agonists and Antagonists
AU - Yoshida, Megumi
AU - Yamamiya, Ryodai
AU - Shimizu, Yuto
AU - Yoshimura, Kenjiro
N1 - Funding Information:
This study was supported by the Japan Agency for Medical Research and Development (AMED/PRIME) under grant number JP18gm5810013 and the Japan Society for the Promotion of Science KAKENHI under grant number 17K07370 to KY. The authors thank Suguru Hashimoto for the help in phototaxis assay.
Publisher Copyright:
© Copyright © 2020 Yoshida, Yamamiya, Shimizu and Yoshimura.
PY - 2020/9/29
Y1 - 2020/9/29
N2 - Transient receptor potential ankyrin 1 (TRPA1) channel is an ion channel whose gating is controlled by agonists, such as allyl isothiocyanate (AITC), and temperature. Since TRPA1 is associated with various disease symptoms and chemotherapeutic side effects, it is a frequent target of drug development. To facilitate the screening of TRPA1 agonists and antagonists, this study aimed to develop a simple bioassay for TRPA1 activity. To this end, transgenic Chlamydomonas reinhardtii expressing human TRPA1 was constructed. The transformants exhibited positive phototaxis at high temperatures (≥20°C) but negative phototaxis at low temperatures (≤15°C); wild-type cells showed positive phototaxis at all temperatures examined. In the transgenic cells, negative phototaxis was inhibited by TRPA1 antagonists, such as HC030031, A-967079, and AP18, at low temperatures. Negative phototaxis was induced by TRPA1 agonists, such as icilin and AITC, at high temperatures. The effects of these agonists were blocked by TRPA1 antagonists. In wild-type cells, none of these substances had any effects on phototaxis. These results indicate that the action of TRPA1 agonists and antagonists can be readily assessed using the behavior of C. reinhardtii expressing human TRPA1 as an assessment tool.
AB - Transient receptor potential ankyrin 1 (TRPA1) channel is an ion channel whose gating is controlled by agonists, such as allyl isothiocyanate (AITC), and temperature. Since TRPA1 is associated with various disease symptoms and chemotherapeutic side effects, it is a frequent target of drug development. To facilitate the screening of TRPA1 agonists and antagonists, this study aimed to develop a simple bioassay for TRPA1 activity. To this end, transgenic Chlamydomonas reinhardtii expressing human TRPA1 was constructed. The transformants exhibited positive phototaxis at high temperatures (≥20°C) but negative phototaxis at low temperatures (≤15°C); wild-type cells showed positive phototaxis at all temperatures examined. In the transgenic cells, negative phototaxis was inhibited by TRPA1 antagonists, such as HC030031, A-967079, and AP18, at low temperatures. Negative phototaxis was induced by TRPA1 agonists, such as icilin and AITC, at high temperatures. The effects of these agonists were blocked by TRPA1 antagonists. In wild-type cells, none of these substances had any effects on phototaxis. These results indicate that the action of TRPA1 agonists and antagonists can be readily assessed using the behavior of C. reinhardtii expressing human TRPA1 as an assessment tool.
KW - Chlamydomonas reinhardtii
KW - TRP channel
KW - TRPA1
KW - bioassay
KW - cell motility
KW - cilia and flagella
KW - drug development
KW - phototaxis
UR - http://www.scopus.com/inward/record.url?scp=85092506246&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85092506246&partnerID=8YFLogxK
U2 - 10.3389/fphar.2020.578955
DO - 10.3389/fphar.2020.578955
M3 - Article
AN - SCOPUS:85092506246
SN - 1663-9812
VL - 11
JO - Frontiers in Pharmacology
JF - Frontiers in Pharmacology
M1 - 578955
ER -